Efficacy of moclobemide in a rat model of neurotoxicant-induced edema

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 5, 2007, Pages 556-561

  Girard, Philippe ^a   Verniers, Danielle ^a   Pansart, Yannick ^a   Gillardin, Jean Marie ^a  

^a Service de Pharmacologie   (France)

Author keywords

Edema; Moclobemide; Neurotoxicant protection

Indexed keywords

MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; TRIETHYLTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; BRAIN; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EDEMA; FEEDING; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM;

ADMINISTRATION, ORAL; ANIMALS; BODY MASS INDEX; BRAIN EDEMA; CALCIUM; CEREBRAL CORTEX; CHLORIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; INTUBATION, GASTROINTESTINAL; MALE; MOCLOBEMIDE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; NEUROTOXICITY SYNDROMES; POTASSIUM; RATS; RATS, WISTAR; SODIUM; TIME FACTORS; TREATMENT OUTCOME; TRIETHYLTIN COMPOUNDS; WATER;

EID: 34548158495     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-042     Document Type: Article

References (35)

1. Bentue-Ferrer, D., Reymann, J.M., Van den Driessche, J., Allain, H., and Bagot, H. 1985. Effect of triethyltin chloride on the central aminergic neurotransmitters and their metabolites: relationship with pathophysiology of aging. Exp. Aging Res. 11: 137-141.
2. Bonnet, U., Leniger, T., and Wiemann, M. 2000. Moclobemide reduces intracellular pH and neuronal activity of CA3 neurones in guinea-pig hippocampal slices-implication for its neuroprotective properties. Neuropharmacology, 39: 2067-2074. doi:10. 1016/S0028-3908(00)00033-2.
3. Borzeix, M.G., and Cahn, J. 1984. Cerebral antioedematous effect of Teproside and of some vincamine derivatives. Int. J. Clin. Pharmacol. Res. 4: 259-261.
4. Brand, A., Leibfritz, D., Wolburg, H., and Richter-Landsberg, C. 1997. Interactions of triethyltin-chloride (TET) with the energy metabolism of cultured rat brain astrocytes: studies by multinuclear magnetic resonance spectroscopy. Neurochem. Res. 22: 123-131. doi:10.1023/A:1027303204686.
5. Brody, T.M., and Moore, K.E. 1962. Biochemical aspects of triethyltin toxicity. Fed. Proc. 21: 1103-1106.
6. Burkard, W.P., Bonetti, E.P., Da Prada, M., Martin, J.R., Polc, P., Schaffner, R., et al. 1989. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J. Pharmacol. Exp. Ther. 248: 391-399.
7. Chang, L.W. 1990. The neurotoxicology and pathology of organomercury, organolead, and organotin. J. Toxicol. Sci. 15 (Suppl 4): 125-151.
8. Chiou, S.H., Ku, H.H., Tsai, T.H., Lin, H.L., Chen, L.H., Chien, C.S., et al. 2006. Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway. Br. J. Pharmacol. 148: 587-598. doi:10.1038/sj.bjp.0706766.
9. Cristofol, R.M., Gasso, S., Vilchez, D., Pertusa, M., Rodriguez-Farre, E., and Sanfeliu, C. 2004. Neurotoxic effects of trimethyltin and triethyltin on human fetal neuron and astrocyte cultures: a comparative study with rat neuronal cultures and human cell lines. Toxicol. Lett. 152: 35-46. doi:10.1016/j.toxlet.2004.03. 023.
10. Da Prada, M., Kettler, R., Keller, H.H., Burkard, W.P., Muggli-Maniglio, D., and Haefely, W.E. 1989. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J. Pharmacol. Exp. Ther. 248: 400-414.
11. Demougeot, C., Van Hoecke, M., Bertrand, N., Prigent-Tessier, A., Mossiat, C., Beley, A., and Marie, C. 2004. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2′-dipyridyl in the rat photothrombotic ischemic stroke model. J. Pharmacol. Exp. Ther. 311: 1080-1087. doi:10.1124/jpet.104. 072744.
12. Egan, C.G. 2006. Differentiation of hippocampal stem cells into functional neurons: evolving our understanding of monoamine oxidase-A inhibition. Br. J. Pharmacol. 148: 563-564. doi:10. 1038/sj.bjp.0706768.
13. Fitton, A., Faulds, D., and Goa, K.L. 1992. Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness. Drugs, 43: 561-596.
14. Getova, D., Dimitrova, D., and Roukounakis, I. 2003. Effects of the antidepressant drug moclobemide on learning and memory in rats. Methods Find. Exp. Clin. Pharmacol. 25: 811-815. doi:10. 1358/mf.2003.25.10.793330.
15. Haefely, W., Burkard, W.P., Cesura, A., Colzi, A., Kettler, R., Lorez, H.P., et al. 1993. Pharmacology of moclobemide. Clin. Neuropharmacol. 16 (Suppl 2): S8-S18.
16. Kirschner, D.A., and Sapirstein, V.S. 1982. Triethyl tin-induced myelin oedema: an intermediate swelling state detected by X-ray diffraction. J. Neurocytol. 11: 559-569. doi:10.1007/ BF01262424.
17. Lang-Lazdunski, L., Blondeau, N., Jarretou, G., Lazdunski, M., and Heurteaux, C. 2003. Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J. Vasc. Surg. 38: 564-575.
18. Li, Y.F., Liu, Y.Q., Huang, W.C., and Luo, Z.P. 2003. Cytoprotective effect is one of common action pathways for antidepressants. Acta Pharmacol. Sin. 24: 996-1000.
19. Li, Y.F., Zhang, Y.Z., Liu, Y.Q., Wang, H.L., Yuan, L., and Luo, Z.P. 2004. Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice. Acta Pharmacol. Sin. 25: 1408-1412.
20. Linee, P., Quiniou, M.J., Godin, C., and Le Polles, J.B. 1984. Cerebral edema in rats induced by triethyltin. Value and limitations as study method of cerebral antiedema drugs. Ann. Pharm. Fr. 42: 431-442.
21. Lorez, H.P., Harvey, J., Wright, L., Kollar, S., Blaszat, G., Thomas, B., et al. 1990. Moclobemide exhibits neuroprotective effects in hypoxic rat brain. In Pharmacology of cerebral ischemia. Edited by J. Krieglstein and H. Oberpichler. Stuttgart.: Wissenschaftliche Verlagsgesellsschaft mbH, pp. 477-484.
22. McMillan, D.E., and Wenger, G.R. 1985. Neurobehavioral toxicology of trialkyltins. Pharmacol. Rev. 37: 365-379.
23. Myers, K.M., Fiskum, G., Liu, Y., Simmens, S.J., Bredesen, D.E., and Murphy, A.N. 1995. Bcl-2 protects neural cells from cyanide/aglycemia-induced lipid oxidation, mitochondrial injury, and loss of viability. J. Neurochem. 65: 2432-2440.
24. Nakajima, H., Kakui, N., Ohkuma, K., Ishikawa, M., and Hasegawa, T. 2005. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats. J. Pharmacol. Exp. Ther. 312: 472-481.
25. Okuyama, S., Karasawa, Y., Shiratsuchi, A., Araki, H., and Aihara, H. 1988. Protective effects of minaprine on the cerebrum of rodents. Res. Commun. Chem. Pathol. Pharmacol. 60: 381-395.
26. Otani, M., Chatterjee, S.S., Gabard, B., and Kreutzberg, G.W. 1986. Effect of an extract of Ginkgo biloba on triethyltin-induced cerebral edema. Acta Neuropathol. (Berl.), 69: 54-65.
27. Rabinstein, A.A. 2006. Treatment of cerebral edema. Neurologist, 12: 59-73. doi:10.1097/01.nrl.0000186810.62736.f0.
28. Reiter, L., Kidd, K., Heavner, G., and Ruppert, P. 1981. Behavioral toxicity of acute and subacute exposure to triethyltin in the rat. Neurotoxicology, 2: 97-111.
29. Richter-Landsberg, C., and Besser, A. 1994. Effects of organotins on rat brain astrocytes in culture. J. Neurochem. 63: 2202-2209.
30. Roth, M., Mountjoy, C.Q., and Amrein, R. 1996. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br. J. Psychiatry, 168: 149-157.
31. Stahnke, T., and Richter-Landsberg, C. 2004. Triethyltin-induced stress responses and apoptotic cell death in cultured oligodendrocytes. Glia, 46: 334-344. doi:10.1002/glia.10341.
32. Ulugol, A., Karadag, H.C., Dokmeci, D., al Khatib, I., and Dokmeci, I. 1995. The protective effect of moclobemide against hypoxia-induced lethality in mice is not due to a decrease in body temperature. Pharmacol. Biochem. Behav. 51: 245-247. doi:10.1016/0091-3057(94)00366-Q.
33. Verleye, M., Steinschneider, R., Bernard, F.X., and Gillardin, J.M. 2007. Moclobemide attenuates anoxia and glutamate-induced neuronal damage in vitro independently of interaction with glutamate receptor subtypes. Brain Res. 1138: 30-38. doi:10.1016/j. brainres.2006.12.089.
34. Viviani, B., Rossi, A.D., Chow, S.C., and Nicotera, P. 1996. Triethyltin interferes with Ca2+ signaling and potentiates norepinephrine release in PC12 cells. Toxicol. Appl. Pharmacol. 140: 289-295. doi:10.1006/taap.1996. 0224.
35. Yanagisawa, K., Ishigro, H., Kaneko, K., and Miyatake, T. 1990. Acetazolamide inhibits the recovery from triethyl tin intoxication: putative role of carbonic anhydrase in dehydration of central myelin. Neurochem. Res. 15: 483-486. doi:10.1007/ BF00966204.